Fractionated Stereotactic Radiotherapy of Vestibular Schwannomas Accelerates Hearing Loss

FSRT accelerates the naturally occurring hearing loss in patients with vestibular schwannoma. Our findings, using fractionation of radiotherapy, parallel results using single-dose radiation. The radiation dose to the cochlea is correlated to hearing loss measured as the speech reception threshold.